Publication | Closed Access

P742 THE PHARMACOKINETICS OF GS-5816, A PAN-GENOTYPIC HCV NS5A INHIBITOR, IN HCV-UNINFECTED SUBJECTS WITH MODERATE AND SEVERE HEPATIC IMPAIRMENT

Hepatic DisordersHepatologyViral HepatitisLiver PhysiologyMedicineImmunologyHepatitisHepatotoxicityLiver DiseasePharmacologyPharmacokinetics Of Gs-5816Drug-induced Liver Injury